Conavi Medical Corp.
CNVIF
$0.33
$0.000.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.17% | 15.50% | -78.40% | -- | -- |
| Total Depreciation and Amortization | -19.23% | -27.57% | -0.26% | -- | -- |
| Total Amortization of Deferred Charges | -26.42% | 23.05% | 8.14% | -- | -- |
| Total Other Non-Cash Items | -109.06% | -24.50% | 197.48% | -- | -- |
| Change in Net Operating Assets | -179.88% | -130.81% | 235.34% | -- | -- |
| Cash from Operations | -21.16% | -13.58% | -39.07% | -- | -- |
| Capital Expenditure | 87.77% | 61.98% | 31.49% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,377.27% | 1,413.14% | 1,586.94% | -- | -- |
| Cash from Investing | 502.88% | 493.42% | 553.28% | -- | -- |
| Total Debt Issued | -- | -30.39% | 1,913.27% | -- | -- |
| Total Debt Repaid | -63.50% | -25.88% | -34.38% | -- | -- |
| Issuance of Common Stock | 369,966.67% | 317,100.00% | 144,071.43% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 263.47% | 44.86% | 2.49% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.31% | 856.66% | -2,578.85% | -- | -- |